Article open access publication

Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome

Breast Cancer Research, Springer Nature, ISSN 1465-5411

Volume 19, 1, 2017

DOI:10.1186/s13058-017-0812-y, Dimensions: pub.1084252009, PMC: PMC5372339, PMID: 28356166,

Affiliations

Organisations

  1. (1) K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway
  2. (2) Oslo University Hospital, grid.55325.34
  3. (3) Oslo Center for Biostatistics and Epidemiology, Institute of Basic Medical Science, University of Oslo, Oslo, Norway
  4. (4) Akershus University Hospital, grid.411279.8
  5. (5) Norwegian University of Science and Technology, grid.5947.f
  6. (6) University of Helsinki, grid.7737.4
  7. (7) Five3 Genomics, LLC, 95060, Santa Cruz, CA, USA
  8. (8) The University of Texas MD Anderson Cancer Center, grid.240145.6
  9. (9) Addenbrooke's Hospital, grid.120073.7
  10. (10) Cancer Research UK Cambridge Institute, grid.470869.4
  11. (11) Aarhus University Hospital, grid.154185.c, Central Denmark Region
  12. (12) University of Oslo, grid.5510.1
  13. (13) Centre for Cancer Biomedicine, University of Oslo, Oslo, Norway
  14. (14) Department of Computer Science, University of Oslo, Oslo, Norway
  15. (15) Vestre Viken Hospital Trust, grid.459157.b
  16. (16) The Oslo Breast Cancer Research Consortium (OSBREAC) www.osbreac.no, Oslo, Norway

Description

BACKGROUND: Breast cancer is a heterogeneous disease at the clinical and molecular level. In this study we integrate classifications extracted from five different molecular levels in order to identify integrated subtypes. METHODS: Tumor tissue from 425 patients with primary breast cancer from the Oslo2 study was cut and blended, and divided into fractions for DNA, RNA and protein isolation and metabolomics, allowing the acquisition of representative and comparable molecular data. Patients were stratified into groups based on their tumor characteristics from five different molecular levels, using various clustering methods. Finally, all previously identified and newly determined subgroups were combined in a multilevel classification using a "cluster-of-clusters" approach with consensus clustering. RESULTS: Based on DNA copy number data, tumors were categorized into three groups according to the complex arm aberration index. mRNA expression profiles divided tumors into five molecular subgroups according to PAM50 subtyping, and clustering based on microRNA expression revealed four subgroups. Reverse-phase protein array data divided tumors into five subgroups. Hierarchical clustering of tumor metabolic profiles revealed three clusters. Combining DNA copy number and mRNA expression classified tumors into seven clusters based on pathway activity levels, and tumors were classified into ten subtypes using integrative clustering. The final consensus clustering that incorporated all aforementioned subtypes revealed six major groups. Five corresponded well with the mRNA subtypes, while a sixth group resulted from a split of the luminal A subtype; these tumors belonged to distinct microRNA clusters. Gain-of-function studies using MCF-7 cells showed that microRNAs differentially expressed between the luminal A clusters were important for cancer cell survival. These microRNAs were used to validate the split in luminal A tumors in four independent breast cancer cohorts. In two cohorts the microRNAs divided tumors into subgroups with significantly different outcomes, and in another a trend was observed. CONCLUSIONS: The six integrated subtypes identified confirm the heterogeneity of breast cancer and show that finer subdivisions of subtypes are evident. Increasing knowledge of the heterogeneity of the luminal A subtype may add pivotal information to guide therapeutic choices, evidently bringing us closer to improved treatment for this largest subgroup of breast cancer.

Funders

Research Categories

Main Subject Area

Fields of Research

Links & Metrics

NORA University Profiles

Aarhus University

Dimensions Citation Indicators

Times Cited: 34

Field Citation Ratio (FCR): 10.65

Relative Citation ratio (RCR): 2.24

Open Access Info

Pure Gold